News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘BasicResearch’ clear

  • Dana-Farber's David Weinstock, MD, and colleagues report that a novel compound stops B-cell acute lymphoblastic leukemia tumor cell growth in pre-clinical studies; approach may be effective in other cancers as well.

Tags: BasicResearch, Leukemia

  • The Department of Cancer Immunology and AIDS at Dana-Farber is changing its name to the Department of Cancer Immunology and Virology.

Tags: BasicResearch, Immunotherapy

  • Dana-Farber Cancer Institute and Eli Lilly and Company announced a multiyear collaboration to research new medicines under development to fight cancer.

Tags: BasicResearch, Partnerships

  • Dana-Farber's Molecular Cancer Imaging Facility in Boston's Innovation District will use cutting edge technology for research on improving cancer diagnosis and developing precision drugs matched to individual patients.

Tags: BasicResearch, Imaging

  • In a new study published in Nature, Dana-Farber scientists demonstrate how a sudden, isolated shuffling of genetic material — known as chromothripsis — can occur.

Tags: BasicResearch, Genomics

  • A new technology developed at Dana-Farber may make it possible to target "undruggable" proteins and overcome drug resistance by using a cancer cell's own protein-degrading machinery to destroy, not just inhibit, cancer proteins.

Tags: BasicResearch, TargetedTherapy

  • Dana-Farber/Brigham and Women's Cancer Center has a new website to connect patients and physicians with information about precision cancer medicine, including resources on what precision cancer is and how it can be applied to cancer care today.

Tags: BasicResearch, Genomics

  • Bruce Spiegelman, PhD, Dana-Farber Cancer Institute, has received Belgium's most important international scientific prize for his contributions to understanding the mechanisms of metabolic disorders.

Tags: BasicResearch, Honors

  • In a new study, researchers at Dana-Farber Cancer Institute show that disruptions to the activity of cell proteins can reveal which genetic mutations lead to disease and which are mere bystanders.

Tags: BasicResearch

  • Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health in Boston and the Irish Cancer Society have formed the Boston-Ireland Prostate Cancer Collaboration. This new entity will conduct and facilitate exchanges of researchers and knowledge between Boston and Ireland.

Tags: BasicResearch, ProstateCancer

Showing 1-10 of 142 items